The Take Home

The American Heart Association Scientific Sessions were held Nov. 5 to 7 in Chicago, the first time they were conducted in-person since 2019.

Transcatheter Cardiovascular Therapeutics, held Sept. 16 to 19 in Boston, featured the latest clinical science in interventional cardiology, as well as forums on innovative technologies, regulatory matters and other topics.

The European Society of Cardiology Congress was held Aug. 26 to 29 in Barcelona, Spain, and online, having an in-person component for the first time since 2019.

Healio and Cardiology Today present highlights from the virtual American Heart Association Scientific Sessions, held Nov. 13 to 17.

Due to the COVID-19 pandemic, the Transcatheter Cardiovascular Therapeutics meeting was held virtually. TCT Connect, which ran from Oct. 14 to 18, offered the latest in cutting-edge science for interventional cardiologists.

The European Society of Cardiology Congress was, for the first time, held virtually. From Aug. 29 to Sept. 1, the digital experience drew virtual attendees from around the world, to watch and hear the latest on topics ranging from the benefits of SGLT2 inhibition in patients without diabetes to the first randomized trial on the question of whether to stop ACE inhibitors and angiotensin receptor blockers in patients with COVID-19.

In May, the Heart Rhythm Society Annual Scientific Sessions were held virtually for the first time. Attendees were able to access sessions via the HRS Learning Portal at heartrhythm365.org.

This year, the American College of Cardiology Scientific Session was, for the first time, held virtually. Here are some of the highlights selected by experts interviewed by Healio.

The International Symposium on Endovascular Therapy, held Jan. 22 to 25 in Hollywood, Florida, tackled many of the hottest topics in endovascular intervention. To obtain the key take-home messages from ISET 2020, Healio spoke with experts in the field including Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM, from Mount Sinai Health System; Jihad A. Mustapha, MD, FACC, FSCAI, from Advanced Cardiac and Vascular Centers for Amputation Prevention in Grand Rapids, Michigan, and Michigan State University College of Osteopathic Medicine; Constantino S. Peña, MD, FAHA, FSCCT, FSIR, from Miami Cardiac and Vascular Institute and Florida International University Herbert Wertheim College of Medicine; and Kenneth Rosenfield, MD, MHCDS, FACC, FAHA, MSCAI, from Massachusetts General Hospital.

The American Heart Association Scientific Sessions had several presentations with major implications for cardiology, most notably the ISCHEMIA and ISCHEMIA-CKD trials, considered to be the most important findings for management of stable ischemic heart disease in more than a decade.